Crosstalk between the HIF-1 and Toll-like receptor/nuclear factor-κB pathways in the oral squamous cell carcinoma microenvironment.

Shengwei Han,Wenguang Xu,Zhiyong Wang,Xiaofeng Qi,Yufeng Wang,Yanhong Ni,Hao Shen,Qingang Hu,Wei Han
DOI: https://doi.org/10.18632/oncotarget.9329
2016-01-01
Oncotarget
Abstract:Hypoxia is a prominent feature of the microenvironment of solid tumors and may contribute to tumor progression through the oxygen-sensitive transcriptional regulator hypoxia-inducible factor-1 (HIF-1). Chronic inflammation is another typical feature. Inflammatory mediators, including Toll-like receptors (TLRs) and nuclear factor-kappa B (NF-kappa B), play an important role in cancer development. Recent studies have revealed extensive cross-talk between hypoxia and inflammation signaling, though the mechanisms remain unclear. Our results confirm that TLR3 and TLR4 are highly expressed in oral squamous cell carcinoma (OSCC). Activation of TLR3 and TLR4 stimulated the expression of HIF-1 through NF-kappa B. In addition, HIF-1 increased the expression of TLR3 and TLR4 through direct promoter binding. Thus, the TLR/NF-kappa B pathway forms a positive feedback loop with HIF-1. These results indicate a novel cross-talk between the TLR/NF-kappa B and HIF-1 signaling, which may contribute to OSCC initiation and progression. With the elucidation of this novel mechanism, it might serve as a basis for future microenvironment targeted cancer therapy.
What problem does this paper attempt to address?